期刊
EMBO MOLECULAR MEDICINE
卷 12, 期 5, 页码 -出版社
WILEY
DOI: 10.15252/emmm.201910605
关键词
5HT(6) receptor; adolescent cannabis abusers; cognitive deficits; mTOR; synaptic transmission
资金
- CNRS
- INSERM
- University of Montpellier
- Labex EpiGenMed
- Fondation pour la Recherche Medicale (FRM, Physiopathologie de l'Addiction program) [DPA20140629800]
- Fondation FondaMental
- ANR [17-CE16-0013-01]
- Gouvernement de la Nouvelle Caledonie
Cannabis abuse during adolescence confers an increased risk for developing later in life cognitive deficits reminiscent of those observed in schizophrenia, suggesting common pathological mechanisms that remain poorly characterized. In line with previous findings that revealed a role of 5-HT6 receptor-operated mTOR activation in cognitive deficits of rodent developmental models of schizophrenia, we show that chronic administration of increment 9-tetrahydrocannabinol (THC) to mice during adolescence induces a long-lasting activation of mTOR in prefrontal cortex (PFC), alterations of excitatory/inhibitory balance, intrinsic properties of layer V pyramidal neurons, and long-term depression, as well as cognitive deficits in adulthood. All are prevented by administrating a 5-HT6 receptor antagonist or rapamycin, during adolescence. In contrast, they are still present 2 weeks after the same treatments delivered at the adult stage. Collectively, these findings suggest a role of 5-HT6 receptor-operated mTOR signaling in abnormalities of cortical network wiring elicited by THC at a critical period of PFC maturation and highlight the potential of 5-HT6 receptor antagonists as early therapy to prevent cognitive symptom onset in adolescent cannabis abusers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据